secwatch.observer — SEC 8-K summary
======================================

Issuer:     ELITE PHARMACEUTICALS INC /NV/ (ELTP)
CIK:        0001053369
Form:       8-K
Filed at:   2026-06-23T11:02:37+00:00
Accession:  0001493152-26-029700
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 7.01, 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Elite Pharmaceuticals to release FY2026 results on June 29, host call on June 30
--------------------------------------------------------------------------------

- FY2026 (ended March 31, 2026) financial results to be released Monday, June 29, 2026.
- Conference call Tuesday, June 30, 2026 at 11:30 AM EDT; dial-in 1-800-346-7359, conference code 98840.
- General questions due by 5:00 PM EDT on June 26; financial questions by 7:00 PM EDT on June 29.
- Management will provide a corporate update and discuss results during the call.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1053369/000149315226029700/0001493152-26-029700-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1053369/000149315226029700/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-029700

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer